Home » UGANDAN HEALTH MINISTRY TOUTS ACT THERAPY FOR MALARIA
UGANDAN HEALTH MINISTRY TOUTS ACT THERAPY FOR MALARIA
April 5, 2006
The Ugandan Ministry of Health is promoting artemisinin combination therapy (ACT') with artemether/ lumefantrine as a new first-line medication for malaria, which is an increasing problem in the country, killing up to 23 percent of Ugandan children who contract the disease.
J.B. Rwakimari, a doctor with the ministry's Malaria Control Program, noted that oral quinine was the preferred second-line medicine for uncomplicated malaria. During pregnancy, he added, sulfadoxine/-pyrimethamine should be taken instead of the other treatment varieties.
On the heels of the ministry's announcement, Ugandan drugmaker Kampala Pharmaceutical introduced a new ACT, DUACT -- a combination of artesunate and amodiaquine.
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct